Consolidated statements of shareholders' equity - USD ($) $ in Thousands | Common stock | Additional paid-in capital | Accumulated other comprehensive (loss) income | Retained deficit | Total |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |
Balance at the beginning of period at Mar. 31, 2018 | $ 481 | $ 861,263 | $ (17,316) | $ (595,721) | $ 248,707 |
Balance (in shares) at Mar. 31, 2018 | 48,072,187 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | (6,764) | (6,764) |
Stock-based compensation | | 586 | | | 586 |
Vesting of restricted stock awards | | (1) | | | (1) |
Vesting of restricted stock awards (in shares) | 66,720 | | | | |
Taxes related to net share settlement of restricted stock awards | | (122) | | | (122) |
Foreign currency translation adjustment | | | (5,291) | | (5,291) |
Unrealized gain on financial instruments, net of tax benefit | | | (1,785) | | (1,785) |
Pension liability adjustment | | | 153 | | 153 |
Balance at the end of period at Jun. 30, 2018 | $ 481 | 861,726 | (24,239) | (602,078) | 235,890 |
Balance (in shares) at Jun. 30, 2018 | 48,138,907 | | | | |
Balance at the beginning of period at Mar. 31, 2018 | $ 481 | 861,263 | (17,316) | (595,721) | 248,707 |
Balance (in shares) at Mar. 31, 2018 | 48,072,187 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | | (3,523) |
Foreign currency translation adjustment | | | | | (4,639) |
Unrealized gain on financial instruments, net of tax benefit | | | | | (1,347) |
Pension liability adjustment | | | | | 135 |
Balance at the end of period at Sep. 29, 2018 | $ 481 | 862,495 | (23,167) | (598,837) | $ 240,972 |
Balance (in shares) at Sep. 29, 2018 | 48,138,907 | | | | |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Cumulative adjustment for adoption of ASC 606 | ASU 2014-09 | | | | 407 | $ 407 |
Balance at the beginning of period at Jun. 30, 2018 | $ 481 | 861,726 | (24,239) | (602,078) | 235,890 |
Balance (in shares) at Jun. 30, 2018 | 48,138,907 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | 3,241 | 3,241 |
Stock-based compensation | | 769 | | | 769 |
Foreign currency translation adjustment | | | 652 | | 652 |
Unrealized gain on financial instruments, net of tax benefit | | | 438 | | 438 |
Pension liability adjustment | | | (18) | | (18) |
Balance at the end of period at Sep. 29, 2018 | $ 481 | 862,495 | (23,167) | (598,837) | $ 240,972 |
Balance (in shares) at Sep. 29, 2018 | 48,138,907 | | | | |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |
Balance at the beginning of period at Mar. 30, 2019 | $ 481 | 863,978 | (26,132) | (573,634) | $ 264,693 |
Balance (in shares) at Mar. 30, 2019 | 48,142,319 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | (4,099) | (4,099) |
Stock-based compensation | | 811 | | | 811 |
Vesting of restricted stock awards | $ 2 | (56) | | | (54) |
Vesting of restricted stock awards (in shares) | 140,878 | | | | |
Taxes related to net share settlement of restricted stock awards | | (347) | | | (347) |
Foreign currency translation adjustment | | | 333 | | 333 |
Unrealized gain on financial instruments, net of tax benefit | | | (128) | | (128) |
Pension liability adjustment | | | (2) | | (2) |
Balance at the end of period at Jun. 29, 2019 | $ 483 | 864,386 | (25,929) | (577,733) | 261,207 |
Balance (in shares) at Jun. 29, 2019 | 48,283,197 | | | | |
Balance at the beginning of period at Mar. 30, 2019 | $ 481 | 863,978 | (26,132) | (573,634) | 264,693 |
Balance (in shares) at Mar. 30, 2019 | 48,142,319 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | | (453) |
Foreign currency translation adjustment | | | | | (3,457) |
Unrealized gain on financial instruments, net of tax benefit | | | | | (2,929) |
Pension liability adjustment | | | | | 123 |
Balance at the end of period at Sep. 28, 2019 | $ 483 | 865,347 | (32,395) | (574,087) | $ 259,348 |
Balance (in shares) at Sep. 28, 2019 | 48,306,412 | | | | |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |
Balance at the beginning of period at Jun. 29, 2019 | $ 483 | 864,386 | (25,929) | (577,733) | $ 261,207 |
Balance (in shares) at Jun. 29, 2019 | 48,283,197 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | 3,646 | 3,646 |
Stock-based compensation | | 965 | | | 965 |
Vesting of restricted stock awards | | 4 | | | 4 |
Vesting of restricted stock awards (in shares) | 23,215 | | | | |
Taxes related to net share settlement of restricted stock awards | | (8) | | | (8) |
Foreign currency translation adjustment | | | (3,790) | | (3,790) |
Unrealized gain on financial instruments, net of tax benefit | | | (2,801) | | (2,801) |
Pension liability adjustment | | | 125 | | 125 |
Balance at the end of period at Sep. 28, 2019 | $ 483 | $ 865,347 | $ (32,395) | $ (574,087) | $ 259,348 |
Balance (in shares) at Sep. 28, 2019 | 48,306,412 | | | | |
Common stock, par value (in dollars per share) | | | | | $ 0.01 |